Zdrowie i gospodarka · 02/11/2022

FDA Releases Final Guidance on Carcinogenicity Testing for Pharmaceuticals

The US Food and Drug Administration (FDA) has made available a final guidance document outlining an updated approach to assessing the carcinogenic risk of pharmaceuticals, in collaboration with the International Council for Harmonisation (ICH). The new guidance aims to provide a more comprehensive framework for evaluating the potential carcinogenic effects of pharmaceuticals, incorporating both animal and human studies.